Sheeba K Thomas

Sheeba K Thomas

UNVERIFIED PROFILE

Are you Sheeba K Thomas?   Register this Author

Register author
Sheeba K Thomas

Sheeba K Thomas

Publications by authors named "Sheeba K Thomas"

Are you Sheeba K Thomas?   Register this Author

45Publications

948Reads

31Profile Views

Bortezomib, lenalidomide, and dexamethasone with panobinostat for front-line treatment of patients with multiple myeloma who are eligible for transplantation: a phase 1 trial.

Lancet Haematol 2018 Dec;5(12):e628-e640

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026183017
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(18)30174-1DOI Listing
December 2018

Clinical Presentation and Anatomical Location of Orbital Plasmacytomas.

Ophthalmic Plast Reconstr Surg 2018 May/Jun;34(3):258-261

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IOP.0000000000000939DOI Listing
July 2018

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.

BMC Cancer 2018 02 13;18(1):187. Epub 2018 Feb 13.

Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4094-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812202PMC
February 2018

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.

Eur J Haematol 2016 Oct 15;97(4):342-7. Epub 2016 Feb 15.

Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12736DOI Listing
October 2016

Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia.

Ann Hematol 2016 Jan 3;95(2):347-8. Epub 2015 Oct 3.

Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 429, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2516-7DOI Listing
January 2016

Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy.

Open Forum Infect Dis 2016 Jan 28;3(1):ofv211. Epub 2015 Dec 28.

Departments of Infectious Diseases, Infection Control, and Employee Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofv211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751339PMC
January 2016

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia.

Clin Cancer Res 2015 Jun 6;21(11):2538-45. Epub 2015 Mar 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737551PMC
June 2015

Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density.

J Clin Oncol 2014 Oct 25;32(28):3156-62. Epub 2014 Aug 25.

Alyssa K. Kosturakis, Zijing He, Yan Li, Nina Shah, Sheeba K. Thomas, Haijun Zhang, Elisabeth G. Vichaya, Xin Shelley Wang, Charles S. Cleeland, and Patrick M. Dougherty, University of Texas MD Anderson Cancer Center, Houston, TX; Jessica A. Boyette-Davis, York College, York, PA; Gwen Wendelschafer-Crabb and William R. Kennedy, University of Minnesota School of Medicine; and Donald A. Simone, University of Minnesota School of Dentistry, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.54.5418
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.5418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171359PMC
October 2014

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.

Cancer Chemother Pharmacol 2014 Jan 23;73(1):35-42. Epub 2013 Oct 23.

Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 0429, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2314-7DOI Listing
January 2014

Validation of the M. D. Anderson Symptom Inventory multiple myeloma module.

J Hematol Oncol 2013 Feb 5;6:13. Epub 2013 Feb 5.

Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, 77030, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1756-8722-6-13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598689PMC
February 2013

Lymphoma vaccine therapy: next steps after a positive, controlled phase III clinical trial.

Semin Oncol 2012 Jun;39(3):253-62

Department of Lymphoma & Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.02.014DOI Listing
June 2012

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma.

Leuk Lymphoma 2012 Jan 24;53(1):118-22. Epub 2011 Aug 24.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.606942DOI Listing
January 2012

Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.

Cancer 2011 Oct 22;117(19):4468-74. Epub 2011 Mar 22.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26031DOI Listing
October 2011

Novel agents for relapsed and/or refractory multiple myeloma.

Cancer J 2009 Nov-Dec;15(6):485-93

Division of Cancer Medicine, Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Unit 429, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3181c51cbaDOI Listing
January 2011

Effect of long-term storage in TRIzol on microarray-based gene expression profiling.

Cancer Epidemiol Biomarkers Prev 2010 Oct 30;19(10):2445-52. Epub 2010 Aug 30.

The Myeloma Tissue and Leukemia Satellite Sample Banks, Department of Lymphoma and Myeloma, University of Texas M D Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966770PMC
October 2010

Lenalidomide in multiple myeloma.

Best Pract Res Clin Haematol 2007 Dec;20(4):717-35

The University of Texas M.D. Anderson Cancer Center, Department of Lymphoma and Myeloma, 1515 Holcombe BLVD, Box 429, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152169260700069
Publisher Site
http://dx.doi.org/10.1016/j.beha.2007.09.002DOI Listing
December 2007